• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Evaluation of vaccination requirements to secure continuous antitoxin immunity to tetanus.

作者信息

Simonsen O, Bentzon M W, Kjeldsen K, Venborg H A, Heron I

出版信息

Vaccine. 1987 Jun;5(2):115-22. doi: 10.1016/0264-410x(87)90057-0.

DOI:10.1016/0264-410x(87)90057-0
PMID:3604393
Abstract

To investigate minimal requirements for tetanus revaccination to secure continuous protection, recently recommended by WHO, 637 subjects with documented vaccination history were studied. Antitoxin concentration in serum relative to time corresponded to a steep decline in the first years after vaccination continuing exponentially. By multiple regression analyses duration of immunity after three-dose primary vaccination was calculated to be 5 years (upper 95% confidence limit of estimated risk of serum antitoxin concentration below 0.01 IU ml-1 still less than 0.1%). Serum antitoxin concentration relative to time after revaccination depended upon age at revaccination and interval from primary vaccination. When given in childhood 5 years after primary vaccination revaccination was calculated to offer protection for approximately equal to 21 years, but protection was considerably shorter when given to the elderly. Cross-sectional and longitudinal analyses were compared and statistical approaches were introduced which may be generally applicable for evaluation of vaccination programmes. It was concluded that a vaccination programme consisting of primary vaccination in infancy and one revaccination 5 years later will secure continuous protection to about the age of 25 years. This is considerably simpler than programmes recommended in many countries, in which risk of hyperimmunization is apparent.

摘要

相似文献

1
Evaluation of vaccination requirements to secure continuous antitoxin immunity to tetanus.
Vaccine. 1987 Jun;5(2):115-22. doi: 10.1016/0264-410x(87)90057-0.
2
Immunity against tetanus and response to revaccination in surgical patients more than 50 years of age.
Surg Gynecol Obstet. 1987 Apr;164(4):329-34.
3
Immunity against tetanus and effect of revaccination 25-30 years after primary vaccination.初次接种疫苗25 - 30年后的破伤风免疫及再次接种的效果
Lancet. 1984 Dec 1;2(8414):1240-2. doi: 10.1016/s0140-6736(84)92796-x.
4
The fall-off in serum concentration of tetanus antitoxin after primary and booster vaccination.
Acta Pathol Microbiol Immunol Scand C. 1986 Apr;94(2):77-82. doi: 10.1111/j.1699-0463.1986.tb02093.x.
5
Revaccination against tetanus 17 to 20 years after primary vaccination: kinetics of antibody response.初次接种破伤风疫苗17至20年后的再次接种:抗体反应动力学
J Trauma. 1987 Dec;27(12):1358-61. doi: 10.1097/00005373-198712000-00007.
6
Fall-off in immunity following diphtheria revaccination--an 8 year follow-up study.
APMIS. 1996 Dec;104(12):921-5. doi: 10.1111/j.1699-0463.1996.tb04959.x.
7
Seroprevalence of tetanus toxoid antibody and booster vaccination efficacy in Japanese travelers.日本旅行者破伤风类毒素抗体的血清流行率和加强免疫接种效果。
J Infect Chemother. 2014 Jan;20(1):35-7. doi: 10.1016/j.jiac.2013.11.003. Epub 2013 Dec 11.
8
Immunity against diphtheria 25-30 years after primary vaccination in childhood.
Lancet. 1985 Apr 20;1(8434):900-2. doi: 10.1016/s0140-6736(85)91675-7.
9
Tetanus immunity in individuals aged 50 years or older in Kashan, Iran.伊朗卡尚50岁及以上人群的破伤风免疫力。
Acta Med Iran. 2011;49(6):379-82.
10
[Epidemiologic data for tetanus prophylaxis. Assessment of the need for vaccination].
Wien Klin Wochenschr. 1999 Oct 29;111(20):851-4.

引用本文的文献

1
Tetanus: recognition and management.破伤风:识别与处理
Lancet Infect Dis. 2025 Jun 18. doi: 10.1016/S1473-3099(25)00292-0.
2
Incidence of Tetanus and Diphtheria in Relation to Adult Vaccination Schedules.破伤风和白喉的发病率与成人免疫接种计划的关系。
Clin Infect Dis. 2021 Jan 27;72(2):285-292. doi: 10.1093/cid/ciaa017.
3
Predictors of the immune response to booster immunisation against tetanus in Czech healthy adults.捷克健康成年人破伤风加强免疫的免疫应答预测因素。
Epidemiol Infect. 2018 Dec;146(16):2079-2085. doi: 10.1017/S095026881800242X. Epub 2018 Aug 23.
4
Tetanus disease and deaths in men reveal need for vaccination.男性破伤风病例及死亡情况显示疫苗接种的必要性。
Bull World Health Organ. 2016 Aug 1;94(8):613-21. doi: 10.2471/BLT.15.166777. Epub 2016 Jun 2.
5
Toll-like receptor 7/8 (TLR7/8) and TLR9 agonists cooperate to enhance HIV-1 envelope antibody responses in rhesus macaques.Toll 样受体 7/8(TLR7/8)和 TLR9 激动剂协同增强恒河猴的 HIV-1 包膜抗体反应。
J Virol. 2014 Mar;88(6):3329-39. doi: 10.1128/JVI.03309-13. Epub 2014 Jan 3.
6
Anyone for tetanus?有人要打破伤风针吗?
BMJ. 1988 Sep 3;297(6648):570-1. doi: 10.1136/bmj.297.6648.570.
7
Detection of tetanus antitoxin using Eu(3+)-labeled anti-human immunoglobulin G monoclonal antibodies in a time-resolved fluorescence immunoassay.在时间分辨荧光免疫分析中使用铕(III)标记的抗人免疫球蛋白G单克隆抗体检测破伤风抗毒素
J Clin Microbiol. 1991 Jul;29(7):1504-7. doi: 10.1128/jcm.29.7.1504-1507.1991.
8
Some unanswered questions about vaccination.关于疫苗接种的一些未解决的问题。
FEMS Microbiol Lett. 1992 Dec 15;100(1-3):475-8. doi: 10.1111/j.1574-6968.1992.tb14079.x.